Zuckerman Investment Group LLC Purchases 82,779 Shares of Henry Schein, Inc. $HSIC

Key Points

• Zuckerman Investment Group LLC increased its holdings in Henry Schein, Inc. by 69.6%, owning 201,639 shares worth approximately $13.81 million.
• Recent analysts' reports show varied target price adjustments for Henry Schein, with Barrington Research lowering its target from $86 to $78, while Stifel Nicolaus set a new target of $75.
• Henry Schein's recent earnings report revealed an EPS of $1.10, missing expectations by $0.09, despite revenue growth of 3.3% year-over-year.

Zuckerman Investment Group LLC lifted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 69.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 201,639 shares of the company's stock after purchasing an additional 82,779 shares during the period. Henry Schein accounts for approximately 1.5% of Zuckerman Investment Group LLC's investment portfolio, making the stock its 28th biggest holding. Zuckerman Investment Group LLC owned approximately 0.17% of Henry Schein worth $13,810,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Farther Finance Advisors LLC increased its stake in shares of Henry Schein by 237.3% during the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock worth $186,000 after purchasing an additional 1,898 shares during the period. State of Alaska Department of Revenue increased its stake in shares of Henry Schein by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock worth $1,000,000 after purchasing an additional 395 shares during the period. Oppenheimer Asset Management Inc. increased its stake in Henry Schein by 5.2% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock worth $941,000 after acquiring an additional 678 shares during the period. GAMMA Investing LLC increased its stake in Henry Schein by 37.8% during the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock worth $270,000 after acquiring an additional 1,081 shares during the period. Finally, Cetera Investment Advisers increased its stake in Henry Schein by 14.7% during the 1st quarter. Cetera Investment Advisers now owns 4,924 shares of the company's stock worth $337,000 after acquiring an additional 630 shares during the period. Institutional investors own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

HSIC has been the topic of a number of recent research reports. Wall Street Zen upgraded Henry Schein from a "hold" rating to a "buy" rating in a research note on Saturday. Evercore ISI upgraded Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective on the stock in a research note on Tuesday, August 26th. JPMorgan Chase & Co. lowered their price objective on Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. UBS Group lowered their price objective on Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 6th. Finally, Robert W. Baird restated a "neutral" rating and set a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Henry Schein has an average rating of "Hold" and a consensus target price of $76.67.

Henry Schein Price Performance

NASDAQ HSIC traded up $0.55 during trading on Friday, hitting $69.58. 1,021,767 shares of the company's stock were exchanged, compared to its average volume of 2,115,911. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The company has a market cap of $8.44 billion, a PE ratio of 22.45, a P/E/G ratio of 2.30 and a beta of 0.81. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The stock's 50 day moving average price is $70.35 and its two-hundred day moving average price is $70.04.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The business had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm's revenue was up 3.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.